NATCO applies to CDSCO for EUA of Molnupiravir capsules to treat COVID-19 EP News Bureau Apr 26, 2021 Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2…
MHRA issues anaphylaxis warning for Pfizer BioNTech vaccine Reuters Dec 10, 2020 Pfizer and BioNTech said they were supporting the MHRA’s investigation
